US Obtains Largest Penalty For Evading HSR Premerger Notification Requirements

The US FTC and DOJ obtained a $12 million penalty against Edwards Lifesciences and Genesis MedTech for structuring the acquisition of JC Medical to intentionally avoid HSR premerger notification thresholds by splitting consideration across a headline purchase price and a contemporaneous investment. The enforcement action signals increased antitrust agency scrutiny of deal structuring designed to evade filing requirements.

This Wire brief sits within Fusion42's coverage of Medtech.